Halozyme Therapeutics, Inc

(NASDAQ:HALO)

Latest On Halozyme Therapeutics, Inc (HALO):

Date/Time Type Description Signal Details
2023-05-10 16:28 ESTNewsHalozyme gains as Piper Sandler upgrades despite Q1 missN/A
2023-05-10 03:24 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.01, revenue of $162.14M misses by $13.38MN/A
2023-05-10 03:24 ESTNewsHalozyme Therapeutics, Inc. (HALO) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 00:27 ESTNewsHalozyme Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-12 18:00 ESTNewsHalozyme's ENHANZE Technology Is The Future Of Biologics DeliveryN/A
2023-03-16 18:38 ESTNewsHot Stocks: PATH, SIG, PD rises on earnings; INTC, QCOM, SWKS upgraded at Susquehanna, FRC, HALO ESPR slideN/A
2023-03-16 18:38 ESTNewsMedicare publishes initial guidance on drug price negotiationsN/A
2023-03-15 11:59 ESTNewsHalozyme sees no impact on royalties after EU body revokes J&J's Darzalex patentN/A
2023-02-26 10:52 ESTNewsHalozyme Therapeutics: A Trailblazer, But With Lukewarm FinancialsN/A
2023-02-22 00:56 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.48 beats by $0.01, revenue of $181.5M misses by $10.55MN/A
2023-02-22 00:56 ESTNewsHalozyme Therapeutics, Inc. (HALO) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 00:56 ESTNewsHalozyme Therapeutics, Inc. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-20 22:26 ESTNewsHalozyme Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-10 23:05 ESTNewsHalozyme issues 2023 revenue, adj. EPS guidance below estimates, shares fall ~7%N/A
2023-01-10 07:28 ESTNewsHalozyme Therapeutics: Chugging AlongN/A
2022-12-21 22:44 ESTNewsHalozyme Therapeutics overweight at Morgan Stanley on Enhanze subcutaneous technologyN/A
2022-11-29 06:34 ESTNewsHalozyme initiated Overweight at Wells Fargo on partnerships, patent moatN/A
2022-11-22 21:07 ESTNewsArgenx subcutaneous drug for neuromuscular disorder gets FDA priority reviewN/A
2022-11-09 06:37 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.74 beats by $0.23, revenue of $208.98M beats by $17.81MN/A
2022-11-09 06:37 ESTNewsHalozyme Therapeutics, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-09 06:37 ESTNewsHalozyme Therapeutics, Inc. (HALO) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 19:37 ESTNewsHalozyme Therapeutics Q3 2022 Earnings PreviewN/A
2022-10-24 08:17 ESTNewsHalozyme Therapeutics: A Pharma Mutual Fund In A Single CompanyN/A
2022-10-24 08:17 ESTNewsHalozyme Looks Good For Their Excellent Royalty Revenue StreamN/A
2022-09-21 09:16 ESTNewsArgenx files for US approval of subcutaneous form of neuromuscular disorder drug efgartigimodN/A
2022-08-16 08:34 ESTNewsHalozyme Therapeutics raises $625M through convertible senior notes due 2028N/A
2022-08-15 16:13 ESTNewsHalozyme launches offering of $500M convertible senior notesN/A
2022-08-15 16:12 ESTNewsHot Stocks: AXDX surges nearly 25%, EMBC gains on earnings, LI slides on mixed earnings, HALO also fallsN/A
2022-08-10 01:02 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.53, revenue of $152.37M; raises FY22 outlookN/A
2022-08-10 01:02 ESTNewsShares of Halozyme add ~9% after hours on Q2 revenue rise, raised FY 2022 guidanceN/A
2022-08-10 01:02 ESTNewsHalozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 03:16 ESTNewsHalozyme Therapeutics Q2 Earnings PreviewN/A
2022-08-03 21:25 ESTNewsHalozyme Therapeutics: One To Put On Your 'Shopping List' For The Next Market Sell-OffN/A
2022-06-07 12:39 ESTNewsHalozyme launches oral testosterone replace therapy TlandoN/A
2022-05-26 12:54 ESTNewsAntares wins full FDA approval for testosterone replacement therapyN/A
2022-05-26 12:52 ESTNewsHot Stocks: Travel stocks rally; SRRA, ATRS jump on merger deals; NSTG plunges; BCYC extends lowN/A
2022-05-26 12:52 ESTNewsAntares Pharma downgraded by Raymond James, 4 others after Halozyme ~$1B acquisition offerN/A
2022-05-19 22:34 ESTNewsHalozyme: Antares Pharma Bolsters Growth ProspectsN/A
2022-05-11 04:20 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.47 misses by $0.02, revenue of $117.3M misses by $10.95MN/A
2022-05-11 04:20 ESTNewsHalozyme Therapeutics, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-11 04:20 ESTNewsHalozyme Therapeutics, Inc. (HALO) CEO Helen Torley on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 06:39 ESTNewsHalozyme Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-14 08:29 ESTNewsAntares Pharma stock soars 49% on ~$1B acquisition deal by HalozymeN/A
2022-04-13 18:14 ESTNewsAntares Pharma stock soars 47% on ~$1B acquisition deal by HalozymeN/A
2022-03-24 12:56 ESTNewsHalozyme Therapeutics licenses ENHANZE drug delivery technology to ChugaiN/A
2022-03-23 03:07 ESTNewsArgenx meets main goal in late-stage trial for subcutaneous myasthenia gravis candidateN/A
2022-02-26 04:01 ESTNewsHalozyme: Steady Revenue Growth At A Reasonable ValuationN/A
2022-02-23 01:11 ESTNewsHalozyme Therapeutics Non-GAAP EPS of $0.42 beats by $0.01, revenue of $102M beats by $2.31MN/A
2022-02-23 01:11 ESTNewsHalozyme Therapeutics, Inc.'s (HALO) CEO Helen Torley On Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-23 01:11 ESTNewsHalozyme Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A

About Halozyme Therapeutics, Inc (HALO):

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in subcutaneous urography and to improve resorption of radiopaque agents. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; Horizon Therapeutics plc; National Institute of Allergy and Infectious Diseases; and Centre for the AIDS Programme of Research in South Africa. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.

See Advanced Chart

General

  • Name Halozyme Therapeutics, Inc
  • Symbol HALO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 136
  • Fiscal Year EndDecember
  • IPO Date2004-03-16
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.halozyme.com
View More

Valuation

  • Trailing PE 47.84
  • Forward PE 29.07
  • Price/Sales (Trailing 12 Mt.) 23.28
  • Price/Book (Most Recent Quarter) 39.44
  • Enterprise Value Revenue 22.37
  • Enterprise Value EBITDA 39.14
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.54
  • Next Year EPS Estimate $2.63
  • Next Quarter EPS Estimate $0.32
  • Profit Margin 48%
  • Operating Margin 54%
  • Return on Assets 16%
  • Return on Equity 106%
  • Revenue 267.59 million
  • Earnings Per Share $0.91
  • Revenue Per Share $1.97
  • Gross Profit 189.99 million
  • Quarterly Earnings Growth 126.8%
View More

Highlights

  • Market Capitalization 5.89 billion
  • EBITDA 145.84 million
  • PE Ratio 23.98
  • PEG Ratio -2.5
  • Analyst Target Price $47.82
  • Book Value Per Share $1.12
View More

Share Statistics

  • Shares Outstanding 135.28 million
  • Shares Float 133.77 million
  • % Held by Insiders 126%
  • % Held by Institutions 102.75%
  • Shares Short 12.42 million
  • Shares Short Prior Month 14.43 million
  • Short Ratio 7.48
  • Short % of Float 10%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.48
  • 52 Week High $56.4
  • 52 Week Low $14.59
  • 50 Day Moving Average 46.6
  • 200 Day Moving Average 38.42
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Halozyme Therapeutics, Inc (HALO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Halozyme Therapeutics, Inc (HALO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$121.7 million$0.50$0.54-7.42%
2020-09-302020-11-02$N/A$0.25$0.2121.89%
2020-06-302020-08-10$N/A$0.19$0.25-22.83%
2020-03-312020-05-11$25.35 million-$0.04-$0.04-3.63%
2019-12-312020-02-24$53.67 million-$0.24-$0.14-67.6%
2019-09-302019-11-12$46.23 million-$0.17-$0.13-33.12%
2019-06-302019-08-06$39.15 million-$0.10-$0.1533.73%
2019-03-312019-05-07$56.95 million$0.01$0.05-78.26%
2018-12-312019-02-21$60.23 million-$0.01-$0.0360.16%
2018-09-302018-11-06$25.56 million-$0.19-$0.2315.67%
2018-06-302018-08-07$35.2 million-$0.16-$0.2225.65%
2018-03-312018-05-10$30.87 million-$0.19-$0.2214.34%
2017-12-312018-02-20$189.56 million$0.85$0.7711.05%
2017-09-302017-11-07$63.73 million$0.02-$0.11118.18%
2017-06-302017-08-08$33.75 million-$0.23-$0.245.54%
2017-03-312017-05-09$29.57 million-$0.26-$0.24-6.34%
2016-12-312017-02-28$39 million-$0.21-$0.3029.48%
2016-09-302016-11-07$31.85 million-$0.23-$0.2613.04%
2016-06-302016-08-09$33.34 million-$0.21-$0.2826.11%
2016-03-312016-05-09$42.5 million-$0.16-$0.2226.84%
2015-12-312016-02-29$52.23 million$0.03-$0.03199.01%
2015-09-302015-11-09$20.78 million-$0.19-$0.16-18.75%
2015-06-302015-08-10$43.38 million$0.02-$0.09122.22%
2015-03-312015-05-11$18.67 million-$0.12-$0.137.69%
2014-12-312015-03-02$30.38 million-$0.04-$0.0633.33%
2014-09-302014-11-10$14.61 million-$0.16-$0.14-14.29%
2014-06-302014-08-11$18.39 million-$0.13-$0.147.14%
2014-03-312014-05-12$11.97 million-$0.22-$0.14-57.14%
2013-12-312014-02-27$12.5 million-$0.19-$0.16-18.75%
2013-09-302013-11-08$16.01 million-$0.17-$0.15-13.33%
2013-06-302013-08-07$14.45 million-$0.20-$0.13-53.85%
2013-03-312013-05-08$11.83 million-$0.17-$0.15-13.33%
2012-12-312013-02-25$21.79 million-$0.04-$0.1573.33%
2012-09-302012-11-08$5.34 million-$0.18-$0.14-28.57%
2012-06-302012-08-06$7.76 million-$0.13-$0.1513.33%
2012-03-312012-05-07$7.44 million-$0.14-$0.11-27.27%
2011-12-312012-03-09$2.41 million-$0.18-$0.15-20%
2011-09-302011-11-07$22.94 million$0.05-$0.04225%
2011-06-302011-08-05$23.19 million$0.03-$0.13123.08%
2011-03-312011-05-06$7.54 million-$0.10-$0.1216.67%
2010-12-312011-03-11$3.57 million-$0.17
2010-09-302010-11-05$3.4 million-$0.13-$0.147.14%
2010-06-302010-08-06$3.21 million-$0.13-$0.147.14%
2010-03-312010-05-07$3.44 million-$0.13-$0.1618.75%
2009-12-312010-03-12$6.44 million-$0.14-$0.1717.65%
2009-09-302009-11-06$3.03 million-$0.16-$0.1811.11%
2009-06-302009-08-07$1.43 million-$0.21-$0.17-23.53%
2009-03-312009-05-08$2.77 million-$0.18-$0.16-12.5%
2008-12-312009-03-13$3.06 million-$0.21-$0.13-61.54%
2008-09-302008-11-06$2.46 million-$0.14-$0.13-7.69%
2008-06-302008-08-08$1.43 million-$0.14-$0.13-7.69%
2008-03-312008-05-08$1.81 million-$0.13-$0.12-8.33%
2007-12-312008-03-13$1.34 million-$0.11-$0.08-37.5%
2007-09-302007-11-08$943000-$0.09-$0.06-50%
2007-06-302007-08-09$709000-$0.07-$0.04-75%
2007-03-312007-05-10$810000-$0.05-$0.050%
2006-12-312007-03-08$427000-$0.07-$0.06-16.67%
2006-09-302006-11-09$362000-$0.06-$0.060%
2006-06-302006-08-10$120000-$0.05-$0.050%
2006-03-312006-05-10$73000-$0.06-$0.05-20%
2005-12-312006-03-23$56000-$0.07-$0.06-16.67%
2005-09-302005-11-11$25000-$0.07-$0.06-16.67%
2005-06-302005-08-08$46000-$0.06-$0.060%
2005-03-312005-05-13$N/A-$0.06-$0.060%
2004-12-312005-03-09$N/A-$0.05-$0.0728.57%
2004-09-302004-11-12$N/A-$0.08-$0.05-60%
2004-06-302004-08-16$N/A-$0.05-$0.04-25%
2004-03-312004-06-01$N/A-$0.08-$0.03-177.33%
2003-12-312004-03-30$26000-$0.01

Halozyme Therapeutics, Inc (HALO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Halozyme Therapeutics, Inc (HALO) Chart:

Halozyme Therapeutics, Inc (HALO) News:

Below you will find a list of latest news for Halozyme Therapeutics, Inc (HALO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Halozyme Therapeutics, Inc (HALO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17300CALL0 0302.06TRUE00
2025-04-17350CALL0 0251.06TRUE00
2025-04-17400CALL0 0206.94TRUE00
2025-04-17450CALL0 0167.62TRUE00
2025-04-175013.3CALL0 4131.58TRUE00
2025-04-17559.2CALL0 1297.45TRUE00
2025-04-17604.1CALL0 28335.9TRUE00
2025-04-17651.4CALL14 134331.82FALSE-0.15-0.1
2025-04-17700.2CALL0 2732.64FALSE00
2025-04-17750CALL0 048.1FALSE00
2025-04-17800CALL0 081.8FALSE00
2025-04-17850CALL0 084.92FALSE00
2025-04-17300PUT0 0192.48FALSE00
2025-04-17350PUT0 0207.22FALSE00
2025-04-17400PUT0 0127.29FALSE00
2025-04-17450PUT0 0104.89FALSE00
2025-04-17500.4PUT0 375.1FALSE00
2025-04-17550.2PUT0 11345.56FALSE00
2025-04-17600.75PUT3 17838.79FALSE0.10.15
2025-04-17652.9PUT10 10432.65TRUE2.90
2025-04-17707.1PUT1 2452.99TRUE7.10
2025-04-17750PUT0 052.37TRUE00
2025-04-17800PUT0 054.25TRUE00
2025-04-17850PUT0 074.68TRUE00
2025-05-163528.5CALL0 1160.76TRUE00
2025-05-16400CALL0 0132.33TRUE00
2025-05-16450CALL0 050.98TRUE00
2025-05-16500CALL0 047.77TRUE00
2025-05-16559.67CALL1 237.62TRUE9.670
2025-05-16605.5CALL1 1041.33TRUE-0.82-0.13
2025-05-16652.95CALL2 1435.85FALSE2.950
2025-05-16701.25CALL6 4735.03FALSE-0.15-0.11
2025-05-16750CALL0 035.17FALSE00
2025-05-16800CALL0 038.67FALSE00
2025-05-16850CALL0 046.62FALSE00
2025-05-16900CALL0 053.83FALSE00
2025-05-16350PUT0 099.66FALSE00
2025-05-16400PUT0 087.49FALSE00
2025-05-16450PUT0 074.99FALSE00
2025-05-16500PUT0 044.96FALSE00
2025-05-16550.9PUT50 245.21FALSE0.120.15
2025-05-16602.05PUT101 1242.19FALSE0.270.15
2025-05-16654.22PUT2 1336.7TRUE4.220
2025-05-16700PUT0 037.16TRUE00
2025-05-16750PUT0 038.14TRUE00
2025-05-16800PUT0 045.87TRUE00
2025-05-16850PUT0 051.39TRUE00
2025-05-16900PUT0 056.98TRUE00
2025-06-2022.50CALL0 0193.09TRUE00
2025-06-202530.5CALL0 0166.8TRUE00
2025-06-20300CALL0 0147.4TRUE00
2025-06-203514.93CALL0 1163.52TRUE00
2025-06-204021.5CALL0 751.1TRUE00
2025-06-204517.3CALL0 6648.46TRUE00
2025-06-205014.6CALL0 10444.45TRUE00
2025-06-205511.1CALL0 28239.32TRUE00
2025-06-20606.95CALL1 24237.45TRUE6.950
2025-06-20654.07CALL18 30235.51FALSE-0.23-0.05
2025-06-20702CALL0 21824.22FALSE00
2025-06-20751.1CALL0 1132.45FALSE00
2025-06-20800.2CALL0 1635.04FALSE00
2025-06-20850.34CALL0 843.17FALSE00
2025-06-20900CALL0 040.54FALSE00
2025-06-2022.50.05PUT0 5127.42FALSE00
2025-06-20250PUT0 0115.68FALSE00
2025-06-20300.09PUT0 8783.15FALSE00
2025-06-20350.35PUT0 5293.93FALSE00
2025-06-20400.7PUT0 1772.19FALSE00
2025-06-20451.49PUT0 4546.06FALSE00
2025-06-20500.75PUT1 3245.91FALSE0.750
2025-06-20551.41PUT0 3732.4FALSE00
2025-06-20602.8PUT0 1935.16FALSE00
2025-06-20655.1PUT0 536.34TRUE00
2025-06-20707.85PUT2 5135.38TRUE7.850
2025-06-20750PUT0 030.27TRUE00
2025-06-20800PUT0 037.41TRUE00
2025-06-20850PUT0 042.15TRUE00
2025-06-20900PUT0 049.85TRUE00
2025-09-19300CALL0 048.12TRUE00
2025-09-19350CALL0 043.29TRUE00
2025-09-19400CALL0 046.45TRUE00
2025-09-19450CALL0 047.16TRUE00
2025-09-19500CALL0 041.61TRUE00
2025-09-195513.2CALL0 236.79TRUE00
2025-09-19609CALL0 135.2TRUE00
2025-09-19656.81CALL0 3436.35FALSE00
2025-09-19704.1CALL0 25733.4FALSE00
2025-09-19753.1CALL0 2033.46FALSE00
2025-09-19801.65CALL2 24033.29FALSE-0.25-0.13
2025-09-19851.45CALL0 332.55FALSE00
2025-09-19900CALL0 031.59FALSE00
2025-09-19300.48PUT0 464.88FALSE00
2025-09-19351.3PUT0 2072.26FALSE00
2025-09-19401.35PUT0 1449.21FALSE00
2025-09-19450PUT0 039.31FALSE00
2025-09-19503.2PUT0 2134.47FALSE00
2025-09-19550PUT0 038.33FALSE00
2025-09-19606.74PUT0 037.35FALSE00
2025-09-19656.5PUT0 338.57TRUE00
2025-09-19700PUT0 037.75TRUE00
2025-09-19750PUT0 036.64TRUE00
2025-09-19800PUT0 034.13TRUE00
2025-09-19850PUT0 034.77TRUE00
2025-09-19900PUT0 038.88TRUE00
2025-12-1922.535CALL0 360.32TRUE00
2025-12-192535.8CALL0 558.96TRUE00
2025-12-193034.5CALL0 7656.75TRUE00
2025-12-193531.2CALL0 2450TRUE00
2025-12-194026.2CALL0 2448.11TRUE00
2025-12-194522.42CALL0 19944.06TRUE00
2025-12-195017CALL4 41441.53TRUE-0.95-0.05
2025-12-195513.9CALL0 13439.41TRUE00
2025-12-196011.1CALL0 78837.76TRUE00
2025-12-19658.45CALL1 6337.42FALSE8.450
2025-12-19706.1CALL8 57635.67FALSE6.10
2025-12-19754.25CALL0 10734.72FALSE00
2025-12-19803.9CALL0 13733.95FALSE00
2025-12-19851.42CALL0 333.27FALSE00
2025-12-19902.25CALL0 1032.82FALSE00
2025-12-19951.25CALL1 335.42FALSE1.250
2025-12-1922.50.05PUT0 1477.58FALSE00
2025-12-19250.85PUT0 1680.85FALSE00
2025-12-19301PUT0 1060.89FALSE00
2025-12-19352.29PUT0 249.47FALSE00
2025-12-19401.29PUT0 16540.51FALSE00
2025-12-19451.61PUT0 23643.91FALSE00
2025-12-19502.47PUT0 12041.47FALSE00
2025-12-19553.9PUT25 16639.33FALSE3.90
2025-12-19605.5PUT0 3538.21FALSE00
2025-12-19657.61PUT0 4939.83TRUE00
2025-12-197012PUT0 135.66TRUE00
2025-12-19750PUT0 036.9TRUE00
2025-12-19800PUT0 034.68TRUE00
2025-12-19850PUT0 032.2TRUE00
2025-12-19900PUT0 034.27TRUE00
2025-12-19950PUT0 037.44TRUE00

Latest HALO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST49$43.1
Jun 13, 2022 7:59 PM EST66$43.1
Jun 13, 2022 7:59 PM EST49$43.1
Jun 13, 2022 7:59 PM EST200$43.1
Jun 13, 2022 7:59 PM EST200$43.1

Halozyme Therapeutics, Inc (HALO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000021545719004072/0000215457-19-004072-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000083423720008702/0000834237-20-008702-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000093247119005265/0000932471-19-005265-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000103342719000019/0001033427-19-000019-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000103342720000010/0001033427-20-000010-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/0001104659-19-052329-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000110465920013287/0001104659-20-013287-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000110465920013317/0001104659-20-013317-index.htm
2018-06-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2018-07-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-08-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1159036/000114036118036549/0001140361-18-036549-index.htm
2018-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1159036/000114036118037161/0001140361-18-037161-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1159036/000114036119010688/0001140361-19-010688-index.htm
2019-07-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1159036/000114036119012431/0001140361-19-012431-index.htm
2019-11-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1159036/000114036119019841/0001140361-19-019841-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903618000036/0001159036-18-000036-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903618000037/0001159036-18-000037-index.htm
2018-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903618000039/0001159036-18-000039-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903618000042/0001159036-18-000042-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903618000043/0001159036-18-000043-index.htm
2018-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903618000045/0001159036-18-000045-index.htm
2019-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000002/0001159036-19-000002-index.htm
2019-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000005/0001159036-19-000005-index.htm
2019-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1159036/000115903619000006/0001159036-19-000006-index.htm
2019-03-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000009/0001159036-19-000009-index.htm
2019-03-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000013/0001159036-19-000013-index.htm
2019-03-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000014/0001159036-19-000014-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000019/0001159036-19-000019-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000026/0001159036-19-000026-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903619000027/0001159036-19-000027-index.htm
2019-05-14S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000030/0001159036-19-000030-index.htm
2019-05-14S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000031/0001159036-19-000031-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000043/0001159036-19-000043-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903619000044/0001159036-19-000044-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000046/0001159036-19-000046-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000049/0001159036-19-000049-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000058/0001159036-19-000058-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903619000060/0001159036-19-000060-index.htm
2019-11-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903619000061/0001159036-19-000061-index.htm
2020-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000002/0001159036-20-000002-index.htm
2020-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000004/0001159036-20-000004-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000011/0001159036-20-000011-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000012/0001159036-20-000012-index.htm
2020-02-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1159036/000115903620000013/0001159036-20-000013-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000018/0001159036-20-000018-index.htm
2020-03-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000019/0001159036-20-000019-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000022/0001159036-20-000022-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000024/0001159036-20-000024-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000029/0001159036-20-000029-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903620000030/0001159036-20-000030-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000036/0001159036-20-000036-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903620000037/0001159036-20-000037-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000115903620000043/0001159036-20-000043-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1159036/000115903620000044/0001159036-20-000044-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018008700/0001179110-18-008700-index.htm
2018-08-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018010332/0001179110-18-010332-index.htm
2018-09-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018011302/0001179110-18-011302-index.htm
2018-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018011307/0001179110-18-011307-index.htm
2018-09-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018011416/0001179110-18-011416-index.htm
2018-10-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018012004/0001179110-18-012004-index.htm
2018-12-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911018013625/0001179110-18-013625-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001315/0001179110-19-001315-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001316/0001179110-19-001316-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001318/0001179110-19-001318-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001321/0001179110-19-001321-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001452/0001179110-19-001452-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001931/0001179110-19-001931-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001932/0001179110-19-001932-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001933/0001179110-19-001933-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001934/0001179110-19-001934-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019001935/0001179110-19-001935-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002004/0001179110-19-002004-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002005/0001179110-19-002005-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002006/0001179110-19-002006-index.htm
2019-02-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/0001179110-19-002007-index.htm
2019-02-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002193/0001179110-19-002193-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002462/0001179110-19-002462-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002463/0001179110-19-002463-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002464/0001179110-19-002464-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/0001179110-19-002465-index.htm
2019-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019004936/0001179110-19-004936-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005497/0001179110-19-005497-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005499/0001179110-19-005499-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005501/0001179110-19-005501-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005504/0001179110-19-005504-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005506/0001179110-19-005506-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005508/0001179110-19-005508-index.htm
2019-05-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005511/0001179110-19-005511-index.htm
2019-05-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019005597/0001179110-19-005597-index.htm
2019-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/0001179110-19-007033-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019007125/0001179110-19-007125-index.htm
2019-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019007734/0001179110-19-007734-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911019009165/0001179110-19-009165-index.htm
2020-01-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000294/0001179110-20-000294-index.htm
2020-01-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000298/0001179110-20-000298-index.htm
2020-02-045Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000982/0001179110-20-000982-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000987/0001179110-20-000987-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000989/0001179110-20-000989-index.htm
2020-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020000992/0001179110-20-000992-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001532/0001179110-20-001532-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001533/0001179110-20-001533-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001535/0001179110-20-001535-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001536/0001179110-20-001536-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001579/0001179110-20-001579-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001581/0001179110-20-001581-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001582/0001179110-20-001582-index.htm
2020-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/0001179110-20-001583-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001748/0001179110-20-001748-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001749/0001179110-20-001749-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020001750/0001179110-20-001750-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020002174/0001179110-20-002174-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020002175/0001179110-20-002175-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020002177/0001179110-20-002177-index.htm
2020-03-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020003046/0001179110-20-003046-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020003052/0001179110-20-003052-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020004645/0001179110-20-004645-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005375/0001179110-20-005375-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005376/0001179110-20-005376-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005377/0001179110-20-005377-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005378/0001179110-20-005378-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005379/0001179110-20-005379-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005380/0001179110-20-005380-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020005382/0001179110-20-005382-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm
2020-05-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm
2020-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020008379/0001179110-20-008379-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009018/0001179110-20-009018-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009047/0001179110-20-009047-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009192/0001179110-20-009192-index.htm
2020-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/0001179110-20-009605-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/0001179110-20-009727-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020009905/0001179110-20-009905-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000117911020010606/0001179110-20-010606-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312518266637/0001193125-18-266637-index.htm
2018-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312518334014/0001193125-18-334014-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000119312519037877/0001193125-19-037877-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312519171015/0001193125-19-171015-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312519289955/0001193125-19-289955-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312519291625/0001193125-19-291625-index.htm
2019-11-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1159036/000119312519294791/0001193125-19-294791-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000119312520037814/0001193125-20-037814-index.htm
2018-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2018-08-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2020-04-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1159036/000168386320002633/0001683863-20-002633-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1159036/999999999718009618/9999999997-18-009618-index.htm

Halozyme Therapeutics, Inc (HALO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Halozyme Therapeutics, Inc (HALO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 126%
Institutional Ownership: 10275%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-03Laurie StelzerSVP, Chief Financial OfficerBuy23,119.00105,081.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020000989/0001179110-20-000989-index.htm
2020-02-12Laurie StelzerSVP, Chief Financial OfficerBuy11,262.00108,068.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001581/0001179110-20-001581-index.htm
2020-02-14Laurie StelzerSVP, Chief Financial OfficerBuy7,809.00111,983.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001749/0001179110-20-001749-index.htm
2019-05-02Matthew L. PosardDirectorBuy12,173.00114,924.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005511/0001179110-19-005511-index.htm
2020-02-22Laurie StelzerSVP, Chief Financial OfficerBuy11,392.00120,675.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020002175/0001179110-20-002175-index.htm
2020-04-30Matthew L. PosardDirectorBuy8,829.00123,753.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005382/0001179110-20-005382-index.htm
2020-09-04Masaru MatsudaSVP, General CounselBuy6,884.0013,822.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020009605/0001179110-20-009605-index.htm
2020-10-20Michael J. LaBarreSVP, Chief Technical OfficerSell12,000.0030.43365,148.00146,800.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020010606/0001179110-20-010606-index.htm
2020-09-21Michael J. LaBarreSVP, Chief Technical OfficerSell12,000.0026.91322,884.00158,800.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020009905/0001179110-20-009905-index.htm
2020-02-03Michael J. LaBarreSVP, Chief Technical OfficerBuy11,559.00165,782.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020000992/0001179110-20-000992-index.htm
2020-02-12Michael J. LaBarreSVP, Chief Technical OfficerBuy7,883.00169,376.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001582/0001179110-20-001582-index.htm
2020-08-20Michael J. LaBarreSVP, Chief Technical OfficerSell12,000.0028.30339,564.00170,800.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020009192/0001179110-20-009192-index.htm
2020-02-14Michael J. LaBarreSVP, Chief Technical OfficerBuy5,772.00172,423.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001750/0001179110-20-001750-index.htm
2020-05-20Michael J. LaBarreSVP, Chief Technical OfficerSell21,387.0023.80509,074.76176,187.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm
2020-02-22Michael J. LaBarreSVP, Chief Technical OfficerBuy8,803.00179,231.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020002177/0001179110-20-002177-index.htm
2019-05-02Bernadette ConnaughtonDirectorBuy12,173.0017,954.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005499/0001179110-19-005499-index.htm
2020-07-20Michael J. LaBarreSVP, Chief Technical OfficerSell12,000.0029.01348,072.00182,800.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020008379/0001179110-20-008379-index.htm
2018-08-28RANDAL J KIRK10% Share HolderSell256,860.0018.024,628,617.201,897,610.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2020-05-22Michael J. LaBarreSVP, Chief Technical OfficerBuy18,613.007.14132,896.82194,800.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020006544/0001179110-20-006544-index.htm
2020-05-20Michael J. LaBarreSVP, Chief Technical OfficerBuy21,387.007.14152,703.18197,574.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020006427/0001179110-20-006427-index.htm
2019-10-01Benjamin HickeySVP, Chief Commerical OfficerBuy20,216.0020,216.00https://www.sec.gov/Archives/edgar/data/1159036/000110465919052329/0001104659-19-052329-index.htm
2018-08-27RANDAL J KIRK10% Share HolderSell64,996.0018.221,184,227.122,154,470.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2020-09-11CONNIE MATSUIDirectorSell32,000.0027.06865,792.00216,753.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020009727/0001179110-20-009727-index.htm
2018-08-24RANDAL J KIRK10% Share HolderSell61,428.0018.201,117,989.602,219,466.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2019-05-02Kenneth J KelleyDirectorBuy12,173.00224,924.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005506/0001179110-19-005506-index.htm
2018-08-23RANDAL J KIRK10% Share HolderSell149,353.0018.482,760,043.442,280,894.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2019-05-02CONNIE MATSUIDirectorBuy12,173.00239,924.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005508/0001179110-19-005508-index.htm
2020-03-19Kenneth J KelleyDirectorBuy17,543.0014.19248,933.42242,467.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm
2018-08-22RANDAL J KIRK10% Share HolderSell464,624.0017.498,126,273.762,430,247.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2020-04-30CONNIE MATSUIDirectorBuy8,829.00248,753.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005380/0001179110-20-005380-index.htm
2020-03-19Kenneth J KelleyDirectorBuy17,543.0014.25249,982.49260,010.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm
2020-04-30Bernadette ConnaughtonDirectorBuy8,829.0026,783.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005376/0001179110-20-005376-index.htm
2020-03-19Kenneth J KelleyDirectorBuy17,543.0014.24249,780.74277,553.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020003999/0001179110-20-003999-index.htm
2020-04-30Kenneth J KelleyDirectorBuy8,829.00286,382.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005379/0001179110-20-005379-index.htm
2018-08-21RANDAL J KIRK10% Share HolderSell95,819.0017.151,643,295.852,894,871.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2018-08-16RANDAL J KIRK10% Share HolderSell56,668.0017.24976,956.322,985,054.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2018-08-15RANDAL J KIRK10% Share HolderSell54,397.0017.15932,908.553,041,722.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2018-08-14RANDAL J KIRK10% Share HolderSell180,154.0017.363,127,473.443,096,119.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2020-08-13James M DalyDirectorSell34,337.0029.12999,893.4431,365.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020009018/0001179110-20-009018-index.htm
2018-08-10RANDAL J KIRK10% Share HolderSell120,606.0017.082,059,950.483,276,273.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-08-09RANDAL J KIRK10% Share HolderSell132,591.0017.482,317,690.683,396,879.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-08-08RANDAL J KIRK10% Share HolderSell87,185.0017.521,527,481.203,529,470.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-07-27RANDAL J KIRK10% Share HolderSell29,074.0016.90491,350.603,616,655.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-07-26RANDAL J KIRK10% Share HolderSell89,136.0017.301,542,052.803,645,729.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-07-25RANDAL J KIRK10% Share HolderSell61,741.0017.321,069,354.123,734,865.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-06-29RANDAL J KIRK10% Share HolderSell72,753.0016.971,234,618.413,796,606.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2019-02-14Dimitrios ChondrosSVP, Chief Medical OfficerBuy6,790.0038,389.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002007/0001179110-19-002007-index.htm
2019-02-03Helen TorleyPresident and CEOBuy55,487.00384,973.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019001315/0001179110-19-001315-index.htm
2019-08-03Dimitrios ChondrosSVP, Chief Medical OfficerSell1,328.0016.7022,177.6038,584.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019009165/0001179110-19-009165-index.htm
2018-06-28RANDAL J KIRK10% Share HolderSell76,291.0016.991,296,184.093,869,359.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2018-08-28RANDAL J KIRK10% Share HolderSell175,389.0018.023,160,509.783,900,919.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2018-06-27RANDAL J KIRK10% Share HolderSell31,795.0017.34551,325.303,945,650.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2019-02-06Helen TorleyPresident and CEOBuy31,250.00396,798.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019001452/0001179110-19-001452-index.htm
2019-02-22Dimitrios ChondrosSVP, Chief Medical OfficerBuy3,884.0039,918.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002465/0001179110-19-002465-index.htm
2019-06-01Dimitrios ChondrosSVP, Chief Medical OfficerBuy2,043.0040,618.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019007033/0001179110-19-007033-index.htm
2018-08-27RANDAL J KIRK10% Share HolderSell44,381.0018.22808,621.824,076,308.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2019-02-14Helen TorleyPresident and CEOBuy28,730.00410,981.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002004/0001179110-19-002004-index.htm
2018-08-24RANDAL J KIRK10% Share HolderSell41,944.0018.20763,380.804,120,689.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001846/0001567619-18-001846-index.htm
2018-08-23RANDAL J KIRK10% Share HolderSell101,982.0018.481,884,627.364,162,633.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2018-08-22RANDAL J KIRK10% Share HolderSell317,257.0017.495,548,824.934,264,615.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2019-02-22Helen TorleyPresident and CEOBuy39,354.00436,091.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002462/0001179110-19-002462-index.htm
2018-08-21RANDAL J KIRK10% Share HolderSell65,427.0017.151,122,073.054,581,872.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001727/0001567619-18-001727-index.htm
2020-02-03Helen TorleyPresident and CEOBuy55,487.00459,567.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020000987/0001179110-20-000987-index.htm
2018-08-16RANDAL J KIRK10% Share HolderSell38,695.0017.24667,101.804,643,451.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2018-08-15RANDAL J KIRK10% Share HolderSell37,144.0017.15637,019.604,682,146.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2018-08-14RANDAL J KIRK10% Share HolderSell123,014.0017.362,135,523.044,719,290.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918001313/0001567619-18-001313-index.htm
2020-02-12Helen TorleyPresident and CEOBuy32,795.00472,452.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001579/0001179110-20-001579-index.htm
2018-08-10RANDAL J KIRK10% Share HolderSell82,353.0017.081,406,589.244,842,304.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2020-02-14Helen TorleyPresident and CEOBuy28,730.00484,923.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001748/0001179110-20-001748-index.htm
2018-08-09RANDAL J KIRK10% Share HolderSell90,536.0017.481,582,569.284,924,657.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-08-08RANDAL J KIRK10% Share HolderSell59,533.0017.521,043,018.165,015,193.00https://www.sec.gov/Archives/edgar/data/1159036/000156761918000416/0001567619-18-000416-index.htm
2018-07-27RANDAL J KIRK10% Share HolderSell19,853.0016.90335,515.705,074,726.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-07-26RANDAL J KIRK10% Share HolderSell60,864.0017.301,052,947.205,094,579.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2020-02-22Helen TorleyPresident and CEOBuy39,354.00510,033.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020002174/0001179110-20-002174-index.htm
2018-07-25RANDAL J KIRK10% Share HolderSell42,159.0017.32730,193.885,155,443.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118033904/0001140361-18-033904-index.htm
2018-06-29RANDAL J KIRK10% Share HolderSell49,678.0016.97843,035.665,197,602.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2018-06-28RANDAL J KIRK10% Share HolderSell52,094.0016.99885,077.065,247,280.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2018-06-27RANDAL J KIRK10% Share HolderSell21,710.0017.34376,451.405,299,374.00https://www.sec.gov/Archives/edgar/data/1159036/000114036118030802/0001140361-18-030802-index.htm
2018-06-15Laurie StelzerSVP, Chief Financial OfficerBuy6,875.0054,385.00https://www.sec.gov/Archives/edgar/data/1159036/000117911018008700/0001179110-18-008700-index.htm
2019-02-03HARRY J LEONHARDTSVP, GCBuy15,413.0054,971.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019001318/0001179110-19-001318-index.htm
2019-05-02James M DalyDirectorBuy12,173.0056,873.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005501/0001179110-19-005501-index.htm
2019-02-14HARRY J LEONHARDTSVP, GCBuy7,809.0057,122.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002006/0001179110-19-002006-index.htm
2018-09-07Bernadette ConnaughtonDirectorBuy5,781.005,781.00https://www.sec.gov/Archives/edgar/data/1159036/000117911018011307/0001179110-18-011307-index.htm
2019-05-02Jeffrey William HendersonDirectorBuy12,173.0063,278.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005504/0001179110-19-005504-index.htm
2020-04-30James M DalyDirectorBuy8,829.0065,702.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005377/0001179110-20-005377-index.htm
2019-02-22HARRY J LEONHARDTSVP, GCBuy11,392.0065,814.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002464/0001179110-19-002464-index.htm
2019-04-13HARRY J LEONHARDTSVP, GCBuy6,875.0068,750.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019004936/0001179110-19-004936-index.htm
2020-04-30Jeffrey William HendersonDirectorBuy8,829.0072,107.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005378/0001179110-20-005378-index.htm
2019-05-02JEAN-PIERRE BIZZARIDirectorBuy12,173.0073,485.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019005497/0001179110-19-005497-index.htm
2019-02-14Laurie StelzerSVP, Chief Financial OfficerBuy7,809.0073,742.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002005/0001179110-19-002005-index.htm
2019-02-03Laurie StelzerSVP, Chief Financial OfficerBuy23,119.0074,250.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019001316/0001179110-19-001316-index.htm
2020-04-30JEAN-PIERRE BIZZARIDirectorBuy8,829.0082,314.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020005375/0001179110-20-005375-index.htm
2019-02-22Laurie StelzerSVP, Chief Financial OfficerBuy11,392.0082,434.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019002463/0001179110-19-002463-index.htm
2019-06-15Laurie StelzerSVP, Chief Financial OfficerBuy6,875.0085,370.00https://www.sec.gov/Archives/edgar/data/1159036/000117911019007734/0001179110-19-007734-index.htm
2020-02-12Masaru MatsudaSVP, General CounselBuy4,130.008,619.00https://www.sec.gov/Archives/edgar/data/1159036/000117911020001583/0001179110-20-001583-index.htm